Fig. 3From: Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysisSubgroup analysis of pooled HRs for OS in cancer patients. a Subgroup analysis stratified by type of cancer. b Subgroup analysis stratified by sample size. c Subgroup analysis stratified by follow-up time. d Subgroup analysis stratified by NOS scoreBack to article page